Point-of-care testing in an organ procurement organization donor management setting.
| Autor: | Baier KA; Midwest Transplant Network, Westwood, KS 66205, USA. kbaier@mwob.org, Markham LE, Flaigle SP, Nelson PW, Shield CF, Muruve NA, Aeder MI, Murillo D, Bryan CF |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Clinical transplantation [Clin Transplant] 2003; Vol. 17 Suppl 9, pp. 48-51. |
| DOI: | 10.1034/j.1399-0012.17.s9.9.x |
| Abstrakt: | Purpose: Our organ procurement organization (OPO) evaluated the clinical and financial efficacy of point-of-care testing (POCT) in management of our deceased organ donors. Methods: Before we implemented point-of care testing with the i-STAT into routine clinical donor management, we compared the i-STAT result with the result from the respective donor hospital lab (DHL) for certain analytes on 15 consecutive donors in our OPO from 26 March to 14 May 2001. The financial impact was studied by reviewing 77 donors from July 2001 to March 2002. Results: There was a strong correlation for each analyte between the POC and DHL test results with r-values as follows: pH 0.86; PCO2 = 0.96; PO2 = 0.98; sodium = 0.98; potassium = 0.95; chloride = 0.94; BUN = 0.98; glucose = 0.92; haematocrit = 0.87 and creatinine = 0.95. Since our OPO coordinators began using i-STAT in their routine clinical management of organ donors, they can now more quickly maximize oxygenation and fluid management of the donor and make extra-renal placement calls sooner. Finally, since we are no longer being billed for the testing performed on the i-STAT, average financial savings to our OPO are US dollars 733 per case. Conclusions: Point-of-care testing in management of our OPO donors provides a result that is equivalent to that of the donor hospital lab, has quicker turn-around time than the donor hospital laboratory, allowing more immediate clinical management decisions to be made so that extra-renal offers may begin sooner. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|